- Home
- ACAD vs UTF Comparison
ACAD vs UTF Comparison
Compare ACAD & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- UTF
- Stock Information
- Founded
- ACAD 1993
- UTF 2004
- Country
- ACAD United States
- UTF United States
- Employees
- ACAD N/A
- UTF N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- UTF Finance Companies
- Sector
- ACAD Health Care
- UTF Finance
- Exchange
- ACAD Nasdaq
- UTF Nasdaq
- Market Cap
- ACAD 2.6B
- UTF 2.5B
- IPO Year
- ACAD 2004
- UTF N/A
- Fundamental
- Price
- ACAD $16.30
- UTF $25.76
- Analyst Decision
- ACAD Buy
- UTF
- Analyst Count
- ACAD 19
- UTF 0
- Target Price
- ACAD $26.44
- UTF N/A
- AVG Volume (30 Days)
- ACAD 1.4M
- UTF 266.0K
- Earning Date
- ACAD 11-06-2024
- UTF 01-01-0001
- Dividend Yield
- ACAD N/A
- UTF 8.21%
- EPS Growth
- ACAD N/A
- UTF N/A
- EPS
- ACAD 0.78
- UTF N/A
- Revenue
- ACAD $929,236,000.00
- UTF N/A
- Revenue This Year
- ACAD $37.34
- UTF N/A
- Revenue Next Year
- ACAD $7.25
- UTF N/A
- P/E Ratio
- ACAD $21.00
- UTF N/A
- Revenue Growth
- ACAD 47.06
- UTF N/A
- 52 Week Low
- ACAD $14.15
- UTF $18.15
- 52 Week High
- ACAD $32.59
- UTF $24.49
- Technical
- Relative Strength Index (RSI)
- ACAD 51.17
- UTF 54.61
- Support Level
- ACAD $16.02
- UTF $24.82
- Resistance Level
- ACAD $16.68
- UTF $26.30
- Average True Range (ATR)
- ACAD 0.58
- UTF 0.29
- MACD
- ACAD -0.09
- UTF 0.08
- Stochastic Oscillator
- ACAD 25.70
- UTF 63.51
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
About UTF Cohen & Steers Infrastructure Fund Inc
Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.